Bolt Biotherapeutics, Inc. (BOLT)
6.41
-0.13
(-1.99%)
USD |
NASDAQ |
Nov 09, 16:00
6.41
0.00 (0.00%)
After-Hours: 19:48
Bolt Biotherapeutics Total Return Level : 6.54 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 6.54 |
| November 05, 2026 | 6.38 |
| November 04, 2026 | 6.54 |
| November 03, 2026 | 6.57 |
| November 02, 2026 | 6.24 |
| October 30, 2026 | 6.59 |
| October 29, 2026 | 6.36 |
| October 28, 2026 | 6.58 |
| October 27, 2026 | 6.37 |
| October 26, 2026 | 6.59 |
| October 23, 2026 | 6.27 |
| October 22, 2026 | 4.19 |
| October 21, 2026 | 4.14 |
| October 20, 2026 | 4.31 |
| October 19, 2026 | 4.04 |
| October 16, 2026 | 4.00 |
| October 15, 2026 | 4.24 |
| October 14, 2026 | 3.98 |
| October 13, 2026 | 4.285 |
| October 12, 2026 | 4.24 |
| October 09, 2026 | 4.11 |
| October 08, 2026 | 3.65 |
| October 07, 2026 | 3.60 |
| October 06, 2026 | 3.51 |
| October 05, 2026 | 3.499 |
| Date | Value |
|---|---|
| October 02, 2026 | 3.45 |
| October 01, 2026 | 3.51 |
| September 30, 2026 | 3.68 |
| September 29, 2026 | 3.60 |
| September 28, 2026 | 3.460 |
| September 25, 2026 | 3.58 |
| September 24, 2026 | 3.59 |
| September 23, 2026 | 3.65 |
| September 22, 2026 | 3.71 |
| September 21, 2026 | 3.59 |
| September 18, 2026 | 3.56 |
| September 17, 2026 | 3.345 |
| September 16, 2026 | 3.63 |
| September 15, 2026 | 4.03 |
| September 14, 2026 | 3.98 |
| September 11, 2026 | 3.95 |
| September 10, 2026 | 3.73 |
| September 09, 2026 | 3.678 |
| September 08, 2026 | 3.86 |
| September 04, 2026 | 3.90 |
| September 03, 2026 | 3.895 |
| September 02, 2026 | 3.84 |
| September 01, 2026 | 4.07 |
| August 31, 2026 | 3.98 |
| August 28, 2026 | 3.815 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Caribou Biosciences, Inc. | 0.4487 |
| Arrowhead Pharmaceuticals, Inc. | 58.16 |
| Oncolytics Biotech, Inc. | 0.4394 |
| Sangamo Therapeutics, Inc. | 0.114 |
| Sarepta Therapeutics, Inc. | 17.82 |